June 9, 2026 Phase 1 Trial Shows Safety and Immunogenicity of LASSARAB Lassa Fever and Rabies Vaccine
April 28, 2026 Top Biotech News: Novartis Earnings Dip, FDA Moves to Pull Amgen Drug, Lilly’s Gene Editing Deal
April 28, 2026 Erasca’s RAS-Targeting Drug Shows Promising Results in Pancreatic and Lung Cancer Trials
April 25, 2026 FDA Accelerates Psychedelic Drug Review with Priority Review Vouchers for Compass, Usona and Transcend in Mental Health Push
